Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06249984 · ClinicalTrials.gov registry record · NA

Effects of Tobacco Cut and Nicotine Form on the Abuse Liability of Moist Snuff

A NA study of Tobacco-Related Carcinoma, sponsored by Ohio State University Comprehensive Cancer Center.

Recruiting
Registry status
NA
Development phase
80
Enrollment target
2
Study locations

NCT06249984: Recruiting NA study of Tobacco-Related Carcinoma, sponsored by Ohio State University Comprehensive Cancer Center.

NCT06249984 is a NA study of Tobacco-Related Carcinoma that is actively recruiting participants, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 80 participants, below the 1,501-participant average among 10 other Tobacco-Related Carcinoma trials with a reported enrollment target (95% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06249984, a NA study of Tobacco-Related Carcinoma, is actively recruiting participants, sponsored by Ohio State University Comprehensive Cancer Center.

RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
2
Study locations

Study Summary

This clinical trial tests the effects of tobacco cut and nicotine form on the abuse liability in participants who use moist snuff (smokeless tobacco \[SLT\]). Two features of moist snuff that are key targets of manipulation from the tobacco industry and drivers of its addiction potential are length of tobacco cut (long versus fine) and nicotine form (low versus high levels of nicotine in the free-base form). Finer tobacco cuts and higher levels of free-base nicotine (FBN) result in faster, greater nicotine delivery. Researchers want to gain information on how certain characteristics of moist snuff affect how long people use it, how it delivers nicotine, or how much people like it. This clinical trial may provide justifications for local, state, or federal regulations aimed at reducing the appeal and addictiveness of moist snuff.

Primary Outcome

Will be assessed by a randomized 2x2 within-subjects design to test whether variations in cut and level of FBN are associated with product use among Appalachian moist snuff users. Data will be summarized descriptively, overall and stratified by dependence. The investigators will use linear mixed effects models to assess the main effects of FBN content on moist snuff use duration and amount, self-reported measures, and plasma nicotine delivery (i.e., maximum absorption; total absorption; and spee

Conditions Studied

Interventions

  • PROCEDURE Biospecimen Collection
  • OTHER Survey Administration
  • PROCEDURE Carbon Monoxide Measurement
  • BEHAVIORAL Smokeless Tobacco Use

Study Locations (2)

Ohio

  • Ohio State University Comprehensive Cancer Center - Columbus
  • Center for Tobacco Research - Columbus

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2024-12-20
Est. Completion 2028-01-31
Phase NA

What NCT06249984 shows while recruiting

NCT06249984 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,501-participant average among 10 other Tobacco-Related Carcinoma trials with a reported enrollment target (95% lower).

The record links to 1 condition, with Tobacco-Related Carcinoma appearing as the primary indexed condition, and to 4 interventions - of which Biospecimen Collection is the first listed.

NCT06249984 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT06249984 about?

NCT06249984 is a clinical study titled "Effects of Tobacco Cut and Nicotine Form on the Abuse Liability of Moist Snuff". This clinical trial tests the effects of tobacco cut and nicotine form on the abuse liability in participants who use moist snuff (smokeless tobacco \[SLT\]). Two features of moist snuff that are key targets of manipulation from the tobacco industry and drivers of its addiction potential are length ...

What is the current status of trial NCT06249984?

This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2024-12-20. Estimated completion is 2028-01-31.

What conditions does trial NCT06249984 study?

This clinical trial studies the following conditions: Tobacco-Related Carcinoma.

What interventions are being tested in trial NCT06249984?

The interventions under investigation include: Biospecimen Collection (PROCEDURE), Survey Administration (OTHER), Carbon Monoxide Measurement (PROCEDURE), Smokeless Tobacco Use (BEHAVIORAL).

Who is sponsoring clinical trial NCT06249984?

This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06249984 being conducted?

This trial has 2 study locations across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tobacco-Related Carcinoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06249984's enrollment target sits among peer trials

80 11th of 10 the lowest of 10 other Tobacco-Related Carcinoma trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Tobacco-Related Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06249984, the US trial registry maintained by the National Library of Medicine. NCT06249984 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.